In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
The past two weeks have seen a flurry of U.S. Food and Drug Administration (FDA) approvals of new treatments...
Radiotherapy is a mainstay of cancer treatment. In recent years, improved technology has allowed many cancer patients to receive...
Pancreatic cancer remains a challenging disease to treat, with a five-year survival rate of less than 9 percent, according...
Wen-Yang Lin, PhD, MS, currently a postdoctoral fellow at Stanford University and the recipient of the 2017 AACR-Genentech Fellowship...
Every month, the editors from the eight scientific journals published by the American Association for Cancer Research (AACR) select...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
Cancer patient advocates take on many roles in their communities. They may go out to churches to promote the...